BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 11, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Gilead, Bristol-Myers sales and marketing update

Gilead increased the wholesale acquisition prices (WAP) in the U.S. for HIV drugs Atripla emtricitabine/tenofovir/efavirenz, Truvada emtricitabine/tenofovir and Emtriva emtricitabine by 5.1%,...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >